These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36338983)

  • 21. The combination of NDUFS1 with CD4
    Wu D; He L; Xu Z; Tian RF; Fan XY; Fan J; Ai J; Bian HJ; Qin WJ; Qin J; Li L
    Front Cell Dev Biol; 2023; 11():1168462. PubMed ID: 37469574
    [No Abstract]   [Full Text] [Related]  

  • 22. The prognostic value and immunological role of the small mother against decapentaplegic proteins in kidney renal clear cell carcinoma.
    Zhang S; Liu Z; Xiao M; Liu H
    Transl Cancer Res; 2021 Jun; 10(6):2678-2693. PubMed ID: 35116580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
    Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
    BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis.
    Tang W; Shao Q; He Z; Zhang X; Li X; Wu R
    BMC Cancer; 2023 Apr; 23(1):303. PubMed ID: 37013511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
    Zhao YW; Ma W; Jiang F; Xie Y; Tang L
    Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma.
    Somsuan K; Aluksanasuwan S
    Genomics Inform; 2023 Jun; 21(2):e22. PubMed ID: 37423640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():632042. PubMed ID: 35515103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
    Sun X; Liu P
    Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
    Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
    J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma.
    Yang X; Mei C; Nie H; Zhou J; Ou C; He X
    Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
    Song J; Yang R; Wei R; Du Y; He P; Liu X
    Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma.
    Geng X; Chi K; Liu C; Fu Z; Wang X; Meng L; Wang H; Cai G; Chen X; Hong Q
    Front Immunol; 2022; 13():982045. PubMed ID: 36353618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and expression of prognostic-related genes in kidney renal clear cell carcinoma and their possible regulatory mechanisms.
    Liu Q; Ding J
    Transl Androl Urol; 2024 Aug; 13(8):1566-1581. PubMed ID: 39280680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
    Zhao T; Li X; Li M; Jamil M; Zhang J
    Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma.
    Xia QD; Li B; Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhang SH; Zhong XY; Zeng N; Ma SY; He HD; Zhang YC; Guan W; Li H; Wang SG
    Front Oncol; 2023; 13():1096341. PubMed ID: 37035135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis.
    Lei P; Zhang M; Li Y; Wang Z
    Front Genet; 2023; 14():996362. PubMed ID: 36999057
    [No Abstract]   [Full Text] [Related]  

  • 40. Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma.
    Lin Y; Chen R; Jiang M; Hu B; Zheng P; Chen G
    Oncol Lett; 2023 Sep; 26(3):379. PubMed ID: 37559574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.